Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SI
126
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $165M | 0.16% |
1,192,225
+653,004
| +121% | +$84.1M |
|
127
W.R. Berkley
WRB
$28.3B
| $165M | 0.16% |
12,835,054
-285,302
| -2% | -$3.66M |
|
128
Cigna
CI
$79.6B
| $164M | 0.16% |
1,876,132
+810,306
| +76% | +$66.3M |
|
129
Ecolab
ECL
$79.6B
| $161M | 0.16% |
1,547,211
-231,526
| -13% | -$24.1M |
|
|
BRSL
130
Brightstar Lottery PLC
BRSL
$1.92B
| $161M | 0.16% |
8,865,958
-235,577
| -3% | -$4.25M |
|
131
Pacira BioSciences
PCRX
$1.05B
| $160M | 0.16% |
2,774,988
+156,574
| +6% | +$8.23M |
|
|
AVP
132
DELISTED
Avon Products, Inc.
AVP
| $159M | 0.16% |
9,261,109
+2,311,111
| +33% | +$43.2M |
|
133
Electronic Arts
EA
$52.4B
| $159M | 0.16% |
6,922,228
+3,294,027
| +91% | +$79M |
|
134
Cinemark Holdings
CNK
$4.09B
| $157M | 0.15% |
4,709,227
-158,371
| -3% | -$5.19M |
|
|
HOT
135
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $155M | 0.15% |
1,946,053
-14,969
| -0.8% | -$1.09M |
|
|
GG
136
DELISTED
Goldcorp Inc
GG
| $154M | 0.15% |
7,127,791
+4,040,503
| +131% | +$94.9M |
|
137
Lear
LEA
$7.45B
| $153M | 0.15% |
1,888,235
-558,786
| -23% | -$43.7M |
|
|
138
UnitedHealth
UNH
$389B
| $152M | 0.15% |
2,021,273
-9,487,506
| -82% | -$682M |
|
|
MFA
139
MFA Financial
MFA
$935M
| $152M | 0.15% |
5,381,584
+563,007
| +12% | +$16.5M |
|
|
WLL
140
DELISTED
Whiting Petroleum Corporation
WLL
| $151M | 0.15% |
8,122
-6,193
| -43% | -$117M |
|
141
Starwood Property Trust
STWD
$6.18B
| $151M | 0.15% |
6,739,838
-56,904
| -0.8% | -$1.2M |
|
142
Bausch Health
BHC
$1.69B
| $144M | 0.14% |
1,229,094
-190,666
| -13% | -$20.9M |
|
143
Bath & Body Works
BBWI
$4.13B
| $143M | 0.14% |
2,866,887
-482,925
| -14% | -$24.1M |
|
144
Constellium
CSTM
$3.96B
| $142M | 0.14% |
6,083,435
+1,153,471
| +23% | +$23.1M |
|
145
CNX Resources
CNX
$4.84B
| $141M | 0.14% |
4,459,453
-71,171
| -2% | -$2.18M |
|
146
Gartner
IT
$10.4B
| $140M | 0.14% |
1,977,344
-229,372
| -10% | -$14.5M |
|
147
Flowserve
FLS
$9.38B
| $140M | 0.14% |
1,775,845
-6,399
| -0.4% | -$443K |
|
|
CTRX
148
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $139M | 0.14% |
2,924,069
+288,194
| +11% | +$13.6M |
|
149
NOV
NOV
$7.11B
| $138M | 0.14% |
1,920,344
-896,915
| -32% | -$65.2M |
|
|
BBBY
150
DELISTED
Bed Bath & Beyond Inc
BBBY
| $136M | 0.13% |
1,699,376
-79,377
| -4% | -$6.14M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.